Urinary F(2)-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes

OBJECTIVE: We have previously reported evidence of an inverse association between a urinary F(2)-isoprostane and type 2 diabetes risk in a pilot case-control study nested within the Insulin Resistance Atherosclerosis Study (IRAS). Here, we report the results from the study extended to the entire IRA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Il'yasova, Dora, Spasojevic, Ivan, Base, Karel, Zhang, Haoyue, Wang, Frances, Young, Sarah P., Millington, David S., D’Agostino, Ralph B., Wagenknecht, Lynne E.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3241306/
https://ncbi.nlm.nih.gov/pubmed/22100959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-1502
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars